During the past decade, Bronx Prevention Research Center CRS conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bronx Prevention Research Center CRS" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 2 trials as a collaborator, "Community Programs for Clinical Research on AIDS" with 1 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Bronx Prevention Research Center CRS" are "HIV Infections" (9 trials), "COVID-19" (1 trials), "Drug Use" (1 trials), "Hepatitis B, Chronic" (1 trials) and "Opioid Use" (1 trials). Many other conditions were trialed in "Bronx Prevention Research Center CRS" in a lesser frequency.

Most popular intervention types in "Bronx Prevention Research Center CRS" are "Drug" (6 trials), "Biological" (2 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "1% tenofovir gel" (1 trials), "CAB LA" (1 trials), "COVID-19 testing and referral for further evaluation, care and/or treatment" (1 trials), "Cabotegravir Oral Tablet" (1 trials) and "Continuous ART" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bronx Prevention Research Center CRS" are 8 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Bronx Prevention Research Center CRS". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in Bronx Prevention Research Center CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bronx Prevention Research Center CRS, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".